Cecilia Yeung

28PUBLICATIONS
289CO-AUTHORS
Molecular targetsPredictive and prognostic markersTransplantation immunologyMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Jun 18, 2026
The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma.

|Mar 04, 2026
Response of B Cells Specific for Polyomavirus-Derived Oncoprotein Is Predictive of Merkel Cell Carcinoma Tumor Control.

Haroldo J Rodriguez Chevez, Allison J Remington, Matthew D Gray

|Feb 14, 2026
Donor-derived del[20q] following allogeneic-hematopoietic cell transplantation: a case with 26-year follow-up and literature review.

Clara Bouley, Min Fang, Jerald Radich

|Jan 23, 2026
Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncology.

Vivian G Oehler, Olga Sala-Torra, Neta Gilderman

|Jan 03, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands.

Shihong Zhang, Tzu-Hao Tang, Sinéad Kinsella

Pageof 5

Frequent Collaborators

5 joint publications

Raphael Gottardo

5 joint publications

Aude G Chapuis

5 joint publications

Valentin Voillet

4 joint publications

Evan W Newell